Skip to content

Zwitterionic Brush-Engineered Molecular Spherical Nucleic Acids for Enhanced Intracellular Antisense Activity.

Aug 2026 · Nano letters (Print) · Vol 26 35, pp. 11784-11791 · 0 citations · 25 references
Medicine

Abstract

Spherical nucleic acids (SNAs) enhance antisense oligonucleotide (ASO) uptake and nuclease resistance, but their activity is often constrained by inefficient intracellular trafficking. Here, we developed a zwitterionic brush-engineered molecular SNA (EmSNA) to improve ASO delivery. EmSNA was constructed by grafting poly(carboxybetaine) side chains onto a unimolecular ASO nanostructure, generating a compact, hydrated, near-neutral corona that modulated interfacial charge, oligonucleotide crowding, and intracellular processing. This architecture preserved rapid, sequence-specific hybridization while increasing duplex thermal stability and nuclease resistance. The zwitterionic brush further enhanced cellular uptake and reduced lysosomal sequestration, thereby improving antisense activity. Using a HER2-targeted ASO as a model cargo, EmSNA achieved stronger HER2 silencing in vitro and greater tumor growth inhibition in a xenograft model after local intratumoral administration, without overt systemic toxicity under the tested conditions. These findings establish zwitterionic brush engineering as an effective strategy to enhance functional SNA-based ASO delivery.

View source

Similar papers

Aug 2026

Enhancing the Membrane Destabilization Capacity of DNA-Surfactant Conjugates for Improved Cytosolic Delivery of Nucleic Acids.

This work describes a chemical approach to deliver multi-tailed DNA-surfactant conjugates into cells using nucleic acid nanocapsules (NANs) and shows that these multi-tailed DSCs improve DNAzyme-mediated gene silencing and enhance mRNA delivery in vitro, owing to their enhanced membrane disruption capabilities reflecte...

Joseph Gorecki, Ina F. de la Fuente, Patrick M. Corrigan et al. · 0 citations
#gene editing Open access Oct 2026

Delivering the Undeliverable: Rational Engineering of Membrane-Based and Synthetic Nanoparticle Platforms

Delivering therapeutic macromolecules to defined cell populations in vivo remains a central unsolved problem in biomedicine. Proteins, nucleic acids and viral vectors are cleared by phagocytes, degraded by enzymes, blocked by endothelial and interstitial barriers, and trapped in acidifying endolysosomes. Pre-existing i...

Qiang-Bing Yang · 0 citations
Open access Sep 2026

Impact of the physico-chemical properties of surface-initiated polymer brushes on siRNA binding and transfection efficiency

Rational design of polycationic gene delivery vectors requires understanding how polymer chemistry governs RNA complexation, cellular uptake, and intracellular release kinetics. Poly(dimethylaminoethyl methacrylate) brushes were found to display striking potential for the delivery of siRNA, with high knockdown efficien...

C. E. Neri-Cruz, D. Carta, Julien E. Gautrot · 1 citation
Review Sep 2026

Engineering extracellular vesicles for targeted siRNA delivery: Advances, therapeutic applications, and clinical translation.

Small interfering RNA (siRNA) therapeutics have emerged as a transformative approach for sequence-specific gene silencing, offering the potential to treat a broad spectrum of diseases by selectively suppressing disease-associated genes. However, the clinical translation of siRNA remains limited by rapid enzymatic degra...

G. S. Amrish Varshan, S. Namasivayam · 0 citations
Open access Aug 2026

Facile synthesis of platinated DNA nanoparticles with radiosensitizing potential

DNA nanostructures are promising drug delivery platforms but often suffer from limited structural stability and high production complexity. Cisplatin can cross-link DNA and act as a therapeutic agent, offering a simplified approach to stabilize DNA nanostructures while incorporating therapeutic functionality. Here, we...

L. Sala, Tomas Perecko, A. Kaňa et al. · 0 citations
Sep 2026

An amino acid cluster-inspired nanoplatform exhibits LAT1-mediated cell targeting for tumor delivery.

Conventional tumor-targeted nanocarriers remain limited by heterogeneous intratumoral distribution, which arises from abnormal tumor vasculature, dense extracellular matrix barriers, and spatially variable receptor expression. These biological barriers restrict deep tumor penetration and prevent homogeneous nanocarrier...

Jin-Yan Liu, Zhi-Jie Fang, Wei-Qing Yue et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.